Maynard Um
-
-
-
-
-
-
-
Altimmune (ALT) PT Lowered to $18 at Evercore ISI
-
-
-
-
-
-
-
Altimmune, Inc. (ALT) Misses Q4 EPS by 2c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Altimmune (ALT)
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Altimmune (ALT)
-
-
-
-
-
-
-
Altimmune, Inc. (ALT) Tops Q1 EPS by 12c
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Altimmune (ALT)
-
-
-
-
-
-
-
Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
-
443,944 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

